Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-10 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.29 | 2e-08 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.28 | 1e-07 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |